BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25161813)

  • 1. The hypothalamic neuropeptide FF network is impaired in hypertensive patients.
    Goncharuk VD; Buijs RM; Jhamandas JH; Swaab DF
    Brain Behav; 2014 Jul; 4(4):453-67. PubMed ID: 25161813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide FF distribution in the human and rat forebrain: a comparative immunohistochemical study.
    Goncharuk VD; Buijs RM; Mactavish D; Jhamandas JH
    J Comp Neurol; 2006 Jun; 496(4):572-93. PubMed ID: 16572434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin (VP) and neuropeptide FF (NPFF) systems in the normal and hypertensive human brainstem.
    Goncharuk VD; Buijs RM; Jhamandas JH; Swaab DF
    J Comp Neurol; 2011 Jan; 519(1):93-124. PubMed ID: 21120930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone neurons in hypertensive patients are activated in the hypothalamus but not in the brainstem.
    Goncharuk VD; Buijs RM; Swaab DF
    J Comp Neurol; 2007 Jul; 503(1):148-68. PubMed ID: 17480022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New central projections of neuropeptide FF: colateral branching pathways in the brainstem and hypothalamus in the rat.
    Jhamandas JH; Jhamandas A; Harris KH
    J Chem Neuroanat; 2001 Mar; 21(2):171-9. PubMed ID: 11312058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide FF modulates neuroendocrine and energy homeostasis through hypothalamic signaling.
    Lin YT; Chen JC
    Chin J Physiol; 2019; 62(2):47-52. PubMed ID: 31243174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of neurohypophyseal neuropeptide-FF (FLFQPQRF-NH2).
    Majane EA; Zhu J; Aarnisalo AA; Panula P; Yang HY
    Endocrinology; 1993 Oct; 133(4):1578-84. PubMed ID: 8404597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment.
    D'Este L; Casini A; Pontieri FE; Renda TG
    Brain Res; 2006 Apr; 1083(1):151-8. PubMed ID: 16529722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of CART neurons in the rat and human hypothalamus.
    Elias CF; Lee CE; Kelly JF; Ahima RS; Kuhar M; Saper CB; Elmquist JK
    J Comp Neurol; 2001 Mar; 432(1):1-19. PubMed ID: 11241374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central neuropeptide FF reduces feed consumption and affects hypothalamic chemistry in chicks.
    Cline MA; Nandar W; Rogers JO
    Neuropeptides; 2007 Dec; 41(6):433-9. PubMed ID: 17936900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of the neuropeptide FF1 receptor (hFF1) in the human hypothalamus and surrounding basal forebrain structures: immunohistochemical study.
    Goncharuk V; Zeng Z; Wang R; MacTavish D; Jhamandas JH
    J Comp Neurol; 2004 Jul; 474(4):487-503. PubMed ID: 15174068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus.
    Jhamandas JH; Simonin F; Bourguignon JJ; Harris KH
    Am J Physiol Regul Integr Comp Physiol; 2007 May; 292(5):R1872-80. PubMed ID: 17289819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galanin immunoreactive neurons in the human hypothalamus: colocalization with vasopressin-containing neurons.
    Gai WP; Geffen LB; Blessing WW
    J Comp Neurol; 1990 Aug; 298(3):265-80. PubMed ID: 1698834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide GEGLSS-like immunoreactivity in the rat central nervous system.
    Aarnisalo AA; Karhunen T; Vanhatalo S; Panula P
    Brain Res Bull; 1997; 44(1):91-6. PubMed ID: 9288835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of neuropeptide W in the rat brain.
    Takenoya F; Yagi M; Kageyama H; Shiba K; Endo K; Nonaka N; Date Y; Nakazato M; Shioda S
    Neuropeptides; 2010 Apr; 44(2):99-106. PubMed ID: 19948359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of neuropeptide FF-like immunoreactivity in the brain of the lizard Gekko gecko and its relation to catecholaminergic structures.
    Smeets WJ; López JM; González A
    J Comp Neurol; 2006 Sep; 498(1):31-45. PubMed ID: 16856160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of basal and morphine-induced neuronal activity by a NPFF(2) selective agonist measured by c-Fos mapping of the mouse brain.
    Moulédous L; Frances B; Zajac JM
    Synapse; 2010 Sep; 64(9):672-81. PubMed ID: 20336629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation.
    Jhamandas JH; Goncharuk V
    Front Endocrinol (Lausanne); 2013; 4():8. PubMed ID: 23404625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide FF, but not prolactin-releasing peptide, mRNA is differentially regulated in the hypothalamic and medullary neurons after salt loading.
    Kalliomäki ML; Panula P
    Neuroscience; 2004; 124(1):81-7. PubMed ID: 14960341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of neuropeptide FF-like immunoreactive structures in the lamprey central nervous system and its relation to catecholaminergic neuronal structures.
    Pombal MA; López JM; de Arriba MC; Megías M; González A
    Peptides; 2006 May; 27(5):1054-72. PubMed ID: 16487629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.